These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22494154)

  • 1. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells.
    Smith NH; Henry KL; Cadwell CM; Bennett A; Hendrickson JE; Frame T; Zimring JC
    Transfusion; 2012 Dec; 52(12):2620-30. PubMed ID: 22494154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.
    Stowell SR; Girard-Pierce KR; Smith NH; Henry KL; Arthur CM; Zimring JC; Hendrickson JE
    Transfusion; 2014 Jan; 54(1):179-89. PubMed ID: 23621760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2.
    Lee S; Bennett PR; Overton T; Warwick R; Wu X; Redman CM
    Am J Obstet Gynecol; 1996 Aug; 175(2):455-9. PubMed ID: 8765268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers.
    Hessner MJ; McFarland JG; Endean DJ
    Transfusion; 1996 Jun; 36(6):495-9. PubMed ID: 8669079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.
    Stowell SR; Henry KL; Smith NH; Hudson KE; Halverson GR; Park JC; Bennett AM; Girard-Pierce KR; Arthur CM; Bunting ST; Zimring JC; Hendrickson JE
    Blood; 2013 Aug; 122(8):1494-504. PubMed ID: 23801629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
    Körmöczi GF; Scharberg EA; Gassner C
    Transfusion; 2009 Apr; 49(4):733-9. PubMed ID: 19347978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Easy Multiplex PCR-SSP Assay for the Genotyping of KEL1 and KEL2 in Multi-transfused Patients.
    Zarghamian P; Pourshadlou M; Mousavi Hosseini K; Sarem F; Shahabi M
    Indian J Hematol Blood Transfus; 2021 Jul; 37(3):489-491. PubMed ID: 34267472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study.
    Ning S; Morin PA; Elahie A; Li N; Liu Y; Barty R; Clarke G; Zeller M; Heddle NM
    Transfusion; 2023 Jan; 63(1):59-68. PubMed ID: 36519693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies.
    Spence WC; Maddalena A; Demers DB; Bick DP
    J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.
    Liu D; Gibb DR; Escamilla-Rivera V; Liu J; Santhanakrishnan M; Shi Z; Xu L; Eisenbarth SC; Hendrickson JE
    Transfusion; 2019 Oct; 59(10):3243-3252. PubMed ID: 31403208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity of KELnull and KELel: a nationwide Austrian survey.
    Körmöczi GF; Wagner T; Jungbauer C; Vadon M; Ahrens N; Moll W; Mühlbacher A; Ozgül-Gülce S; Kleinrath T; Kilga-Nogler S; Schönitzer D; Gassner C
    Transfusion; 2007 Apr; 47(4):703-14. PubMed ID: 17381630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation.
    Girard-Pierce KR; Stowell SR; Smith NH; Arthur CM; Sullivan HC; Hendrickson JE; Zimring JC
    Blood; 2013 Sep; 122(10):1793-801. PubMed ID: 23878139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein.
    Lee-Stroka H; Slezak SL; Adams S; Martin J; Robbins FM; Caruccio L; Byrne KM; Stroncek DF
    Transfusion; 2008 May; 48(5):925-9. PubMed ID: 18248571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review.
    O'Brien KL; Kim YA; Haspel RL; Uhl L
    Transfusion; 2015 Mar; 55(3):599-604; quiz 598. PubMed ID: 25118004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women.
    Böhmova J; Vodicka R; Lubusky M; Holuskova I; Studnickova M; Kratochvilova R; Krejcirikova E; Janikova M; Durdová V; Dolezalová T; Filipová H; Dusek L; Dhaifalah I; Vomackova K; Kacerovsky M; Prochazka M; Vrtel R
    Fetal Diagn Ther; 2016; 40(1):48-53. PubMed ID: 26492079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes.
    Silvy M; Callebaut I; Filosa L; Granier T; Chiaroni J; Bailly P
    Transfusion; 2016 May; 56(5):1223-9. PubMed ID: 26996808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen.
    Hendrickson JE; Hod EA; Spitalnik SL; Hillyer CD; Zimring JC
    Transfusion; 2010 Mar; 50(3):642-8. PubMed ID: 19906034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing for Antenatal Prediction of KEL1 Blood Group Status.
    Rieneck K; Clausen FB; Dziegiel MH
    Methods Mol Biol; 2015; 1310():115-21. PubMed ID: 26024630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.
    Escamilla-Rivera V; Liu J; Gibb DR; Santhanakrishnan M; Liu D; Forsmo JE; Eisenbarth SC; Foxman EF; Stowell SR; Luckey CJ; Zimring JC; Hudson KE; Hendrickson JE
    Blood; 2020 May; 135(22):1983-1993. PubMed ID: 32266378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.